BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16547488)

  • 1. G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+.
    Talarn C; Urbano-Ispizua A; Martino R; Batlle M; Fernández-Avilés F; Herrera C; Pérez-Simón JA; Gaya A; Aymerich M; Pétriz J; Marín P; Sierra J; Montserrat E
    Bone Marrow Transplant; 2006 May; 37(9):873-9. PubMed ID: 16547488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
    Ferrari S; Rovati B; Porta C; Alessandrino PE; Bertolini A; Collovà E; Riccardi A; Danova M
    Cancer Immunol Immunother; 2003 Jun; 52(6):359-66. PubMed ID: 12664135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell counts and their subsets during treatment of multiple myeloma.
    Kovarova L; Buchler T; Pour L; Zahradova L; Ocadlikova D; Svobodnik A; Penka M; Vorlicek J; Hajek R
    Neoplasma; 2007; 54(4):297-303. PubMed ID: 17822319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome.
    Talarn C; Urbano-Ispizua A; Martino R; Pérez-Simón JA; Batlle M; Herrera C; Granell M; Gaya A; Torrebadell M; Fernández-Avilés F; Aymerich M; Marín P; Sierra J; Montserrat E
    Haematologica; 2007 Dec; 92(12):1655-63. PubMed ID: 18055989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
    Huang XJ; Chang YJ; Zhao XY
    Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation.
    Hock BD; Haring LF; Ebbett AM; Patton WN; McKenzie JL
    Bone Marrow Transplant; 2002 Dec; 30(11):733-40. PubMed ID: 12439695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.
    Shaughnessy PJ; Bachier C; Lemaistre CF; Akay C; Pollock BH; Gazitt Y
    Stem Cells; 2006 Jul; 24(7):1789-97. PubMed ID: 16822885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Ann Hematol; 2006 May; 85(5):308-14. PubMed ID: 16525786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of alloimmune responses by dendritic cell subsets.
    Lonial S; Torre C; David E; Harris W; Arellano M; Waller EK
    Exp Hematol; 2008 Oct; 36(10):1309-17. PubMed ID: 18620796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.
    Bolwell B; Sobecks R; Pohlman B; Andresen S; Theil K; Serafino S; Rybicki L; Kalaycio M
    Bone Marrow Transplant; 2003 Jan; 31(2):95-8. PubMed ID: 12621489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Martelli V; Stanzani M; Falcioni S; Bonifazi F; Bandini G; Tura S; Baccarani M; Rondelli D
    Bone Marrow Transplant; 2002 Jun; 29(11):887-91. PubMed ID: 12080352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell recovery after autologous stem cell transplantation.
    Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
    Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on immunotherapy with dendritic cell in leukemic mice model].
    Li XX; Chen XL; Ma DX; Liu CS; He XP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):73-7. PubMed ID: 16732955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
    Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
    Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
    Arellano M; K Waller E
    Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis.
    Buzzeo MP; Yang J; Casella G; Reddy V
    Exp Hematol; 2007 Sep; 35(9):1456-65. PubMed ID: 17761290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.